South Korea Insulin Delivery System Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Insulin Pens, Insulin Pumps, Insulin Syringes, Insulin Jet Injectors), By End-User (Hospitals, Homecare, Specialty Clinics, and Others), and South Korea Insulin Delivery System Market Insights, Industry Trend, Forecasts to 2035.

South Korea Insulin Delivery System Market Insights Forecasts to 2035

• The South Korea Insulin Delivery System Market size is Expected to Grow at a CAGR of around 5.1% from 2025 to 2035
• The South Korea Insulin Delivery System Market size is expected to hold a significant Share by 2035

According to a research report published by Spherical Insights & Consulting, The South Korea Insulin Delivery System Market Size is Anticipated to Grow at a CAGR of 5.1% from 2025 to 2035. The market is driven by rising diabetes prevalence, technological advancements in insulin delivery devices, and supportive government initiatives, the South Korea Insulin Delivery System Market is experiencing rapid adoption among patients and healthcare providers.

Market Overview

The South Korea insulin delivery system market is the portion of the medical device arena for devices implemented for delivering insulin to the diabetes patient population to include insulin pens (both reusable and prefilled), infusion pumps, smart insulin pens, and suitable accessories (pen needles). The use of insulin delivery systems also facilitates glucose management, treatment adherence, and the patient population’s diabetes care in both a hospital and homecare setting. In South Korea, the market is developing at an enormous rate due to the increasing occurrence of diabetes within the aging population of the patient population, as well as the patient population’s growing cognizance of enhanced diabetes management solution options. Also, the products of smart pens and connected infusion pumps are creating technology advancements that will improve dosing precision, monitoring and communications with digital health solutions. There are government initiatives in development and reimbursement options that will facilitate the adoption of devices in the hospital environment and more products are under development for long-term market viability and growth for hospitals. There will ultimately be new product in development and added dyad partnerships developed by hospitals that further implement delivery of insulin products.

Report Coverage

This research report categorizes the market for the South Korea insulin delivery system market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the South Korea insulin delivery system market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the South Korea insulin delivery system market.  

Driving Factors

The South Korea insulin delivery system market is driven by the increasing proliferation of diabetes and an aging population, which increases the demand for effective glucose management solutions. Insulin pen, infusion pump and technological progression in smart devices improves dose accuracy and patient facilities. In addition, the assistant expedits the government's initiative, the expansion of reimbursement coverage, and the growing awareness market about advanced diabetes care.

Restraining Factors

The South Korea Insulin delivery system market is restrained by high device costs, limited awareness of advanced insulin delivery options between patients and regulatory challenges that can delay the product approval. Additionally, insufficient reimbursement coverage for some devices limits broad adoption.

Market Segmentation

The South Korea insulin delivery system market share is classified into product type and end-user.

• The insulin pens segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea insulin delivery system market is segmented by product type into insulin pens, insulin pumps, insulin syringes, and insulin jet injectors. Among these, the insulin pens segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is due to ease of their use, portability and convenience for patients, which encourages high rearing and frequent use. Prefields and reusable pen insulin simplifies administration and are widely preferred by both patients and healthcare providers.

• The homecare segment dominated the market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea insulin delivery system market is segmented by end-user into hospitals, homecare, specialty clinics, and others. Among these, the homecare segment dominated the market share in 2024 and is expected to grow at a significant CAGR during the forecast period. This growth is driven by increasing the patient's priority for increasing awareness about self-instituted insulin therapy, portable delivery equipment convenience, and increasing awareness about effective diabetes management practices outside the hospital settings.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the South Korea insulin delivery system market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Medtronic
• Novo Nordisk
• Sanofi
• Eli Lilly and Company
• F. Hoffmann-La Roche Ltd
• Becton, Dickinson and Company
• SOOIL Developments Co., Ltd
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at South Korea, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the South Korea insulin delivery system market based on the below-mentioned segments:

South Korea Insulin Delivery System Market, By Product Type

• Insulin Pens
• Insulin Pumps
• Insulin Syringes
• Insulin Jet Injectors

South Korea Insulin Delivery System Market, By End-User

• Hospitals
• Homecare
• Specialty Clinics
• Others